Eczema & Skin Rash Treatment Protocol

Category Name	Content
Name	Eczema & Skin Rash Treatment Protocol
Uses	Treatment of eczema and skin rashes, including inflammation, redness, itching, swelling, discomfort, and pain. Promotes faster healing and prevents flare-ups.
Route Of Administration	Topical (creams) or Oral (tablets).
Frequency Of Use	Topical: Apply twice daily for 14 days. Oral: Follow prescription instructions for 7-14 days.
Concentration(s)	Hydrocortisone 2.5% Cream, Triamcinolone 0.1% Cream, Betamethasone 0.05% Cream, Valtrex 1g, Keflex 500mg, Bactrim-DS 800-160mg, Clindamycin 300mg, Augmentin 875-125mg, Doxycycline 100mg.
Maximum Dosage (Day, Wk)	Topical: No more than twice daily. Oral: Follow prescribed dosage.
Contraindications	Pregnancy, breastfeeding (for oral medications), history of liver or kidney disease, immunocompromised status, previous antibiotic treatment in last 14 days, MRSA history, perioral dermatitis, open wounds, or skin infections.
Possible Side Effects	Mild irritation, skin thinning (with steroids), redness, nausea, diarrhea, discoloration, rare allergic reactions, C. difficile infection (with antibiotics).
Compatibility With Other Treatments/Drugs	Check interactions with steroids, antifungals, antibiotics, and immunosuppressants before prescribing.
Allergies	Assess for hypersensitivity to steroids, antibiotics, or antifungal treatments.
Administration Time	Topical: Apply thin layer twice daily. Oral: Take with food and water as prescribed.
Dosing/Settings	- Hydrocortisone 2.5% Cream: Apply a thin layer twice daily for 14 days. - Triamcinolone 0.1% Cream: Apply a thin layer twice daily for 14 days. - Betamethasone 0.05% Cream: Apply a thin layer twice daily for 14 days. - Keflex 500mg: Take one capsule four times daily for 7 days. - Bactrim-DS 800-160mg: Take one tablet twice daily for 7 days. - Clindamycin 300mg: Take one capsule four times daily for 7 days. - Augmentin 875-125mg: Take one tablet twice daily for 7 days. - Doxycycline 100mg: Take one capsule twice daily for 7 days.
Test Spot Requirement	Not required, but recommended for patients with sensitive skin.
Pre-Treatment Guidelines	Avoid excessive sun exposure, harsh soaps, and irritants. Ensure proper skin hydration before applying topical medications.
Provider Clearance Guidelines	Defer if patient has systemic infection, immunosuppression, or MRSA history. Consult for perioral dermatitis, severe rashes, or suspected skin infections requiring cultures.
Pre-Treatment Screening Workflow	1. Age over 18? (If NO, defer unless legal guardian is present). 2. Pregnant or breastfeeding? (If YES, defer oral meds and discuss topical risks). 3. History of liver/kidney disease? (If YES, defer). 4. Treated with antibiotics in past 14 days? (If YES, defer for further evaluation). 5. Symptoms of systemic infection (fever, swollen lymph nodes)? (If YES, defer to urgent care).
What To Do If Adverse Reaction Occurs	For mild irritation, advise discontinuation and hydration. For severe allergic reactions, stop treatment immediately and refer to urgent care.
Clinic Implementation Guidelines	Confirm patient consent. Educate on proper medication use and side effects. Document screening responses and treatment selection.
Photographic Documentation Protocol	Optional but recommended for severe cases.
Post-Treatment Care	Avoid scratching, keep skin moisturized, and follow up if symptoms persist or worsen.
Additional Documentation Requirements	Signed consent, medication logs, allergy check, and prescription records.